In 96% of TGCT patients, the proportion of CD4+ cells exceeded that of CD8+ TIL, with their numbers gradually decreasing from tumor central to peripheral areas, and significantly fewer T cells in tumor-free, contralateral testes. This evidence concerns the gene CD4 and neoplasm.